FairJourney Bio has partnered with AbTherx to bring transgenic mouse-based [...]
Orphan Therapeutics Accelerator has expanded its development network for ultra-rare [...]
Phase 2 trial begins for fetal growth restriction therapy with no approved drug treatments available
The first patients have been dosed in a Phase 2 [...]
CORXEL Pharmaceuticals reported positive Phase 2 results for oral GLP-1 [...]
Meteor Biotech has joined a South Korean government-backed consortium aimed [...]
Inaqovi in combination with venetoclax has received an amended European [...]
TRIMTECH Therapeutics has secured an additional $14 million in seed [...]
Cytomos is presenting its AuraCyt platform at BIO 2026, showcasing [...]
Neurological pathway illustration showing myelin sheath repair; MRI brain imaging; [...]
InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]